11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 249/08 (2006.01) A61K 31/4196 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2488592

Compounds having Formula I, including pharmaceutically acceptable salts, hydrates and solvates thereof: are selective inhibitors of the 11.beta.-HSD1 enzyme. The compounds are useful for the treatment of diabetes, such as noninsulin-dependent diabetes (NIDDM), hyperglycemia, obesity, insulin resistance, dylsipidemia, hyperlipidemia, hypertension, Syndrome X, and other symptoms associated with NIDDM.

La présente invention concerne des composés représentés par la formule (I), y-compris des sels, des hydrates et des solvates pharmaceutiquement admis de ces composés. Ces produits constituent des inhibiteurs sélectifs de l'enzyme 11?-HSD1. Les composés de l'invention conviennent ainsi au traitement du diabète, et notamment du diabète non insulino-dépendant, de l'hyperglycémie, de l'obésité, de la résistance à l'insuline, de la dyslipidémie, de l'hyperlipémie, de l'hypertension, du syndrome X, et d'autres symptômes associés au diabète non insulino-dépendant.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1519623

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.